AZP-3601 Safely Raises Blood Calcium Levels in Trial in Healthy Adults

AZP-3601 Safely Raises Blood Calcium Levels in Trial in Healthy Adults

308083

AZP-3601 Safely Raises Blood Calcium Levels in Trial in Healthy Adults

AZP-3601, an investigational treatment for chronic hypoparathyroidism, was able to safely increase blood calcium levels in healthy volunteers in a Phase 1 clinical trial, top-line data show. “We are pleased with these clinical trial results for AZP-3601 … as they support a potential therapeutic profile that we believe can address the multiple clinical needs of patients with hypoparathyroidism, including a significant number who suffer from or who are at risk of kidney disease, osteopenia or osteoporosis [bone…

You must be logged in to read/download the full post.